September 11th 2024
Wendie Berg. MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Tumor Marker Testing Fact Sheet
August 3rd 2011Tumor marker tests include a variety of tests for cancer that can be performed on cells of a tissue sample from a newly biopsied or stored tumor. Tumor marker testing provides the patient and oncologist with vital information about the tumor at the cellular level, expanding traditional pathology reports that are based on tumor size, appearance and staging of the disease.
Read More
Breast Cancer Awareness: Is the Message Getting Blurred?
August 3rd 2011At 30,000 feet, breast cancer awareness is probably not the first thing on an airline passenger’s mind. But Delta Airlines is trying to change all that. Delta’s “Force for Global Good” is offering $2 glasses of pink lemonade to customers and donating all proceeds to The Breast Cancer Research Foundation (BCRF).
Read More
Barbara's Reflections My Journey Living With Breast Cancer
August 3rd 2011This month is National Breast Cancer Awareness Month and so I feel it's an appropriate time to Reflect on my last eighteen months going down that road. I will try not to make this a sad trip but instead a hopeful one for all of us either with the disease or with loved one's going through this journey.
Read More
Barbara's Reflections: Out on a limb, hanging by my fingertips!
August 3rd 2011This week on the Women's Forum there have been two posts that have "touched home" for me. I must share with you that I was hesitant at first to answer them. Why, you are probably asking... Well they are Both subjects that I am completely familiar with and yet felt reluctant to open-up about on the forum.
Read More
Barbara's Reflections: Not A Victim, Not A Survivor, A Conqueror!
August 3rd 2011Today I stood on the steps of the State House in Austin, Texas along with a thousand or so other good people who were trying to send a message to Congress to spend more money on Cancer research. We were there to support the March for Cancer taking place in our country's Capital, Washington, DC.
Read More
Barbara's Reflections: The Difference Between "Courage" and "Challenge"
August 3rd 2011I was sitting in a chair today waiting for my fingernails to dry and started looking through a recent issue of Readers Digest. On page 50 is a true story about a women named Diana Golden and her journey during the last 28 years.
Read More
You're in Control of the Cancer, It's not in Control of You
August 3rd 2011Janet George is a mother of three, grandmother of seven, and a breast cancer survivor. Her story began after a routine mammogram. Janet's mother died of breast cancer, so regular mammograms have always been part of her healthcare. Janet was notified that a small tumor had been found during a routine mammogram, and her cancer was diagnosed after a wire localization biopsy.
Read More
Latina Singer-Songwriter Speaks Out About Breast Cancer Survival
August 3rd 2011Each year, an estimated 200,000 new cases of breast cancer are diagnosed in the U.S., affecting women of all races, from all walks of life. The disease can strike at any time, as the Latina music star Soraya learned when she was diagnosed in 2000 with breast cancer at the young age of 31.
Read More
10 FAQs About Sentinel node Biopsy for Breast Cancer
August 3rd 2011During the past eighteen years in my medical practice, I’ve had a direct impact (I hope a positive impact) on breast cancer treatment for over a thousand women confronting this diagnosis. During this time span the DECISION MAKING process has become increasingly complex.
Read More
Combining Radiation and Surgery for the Successful Treatment of Breast Cancer
August 3rd 2011I saw a long time patient yesterday in the office. Gloria drops in once a year for a checkup. She brought me a funny birthday card and we teased each other about the effects of gravity and aging. During her exam she detailed for me how much fun she and her husband Francis are having running a small entrepreneurial business (home remodeling).
Read More
Breast cancer is the most common cancer among women. Most of us are aware of the statistic that one out of every eight women will develop breast cancer at some point in their lifetime. However, an important point about this statistic is that most of these cancers do not occur until after the age of 50.
Read More
Doctor, what are these "new" estrogens that do not cause breast cancer?
August 3rd 2011Recently there have been numerous references in the news about the new types of estrogens that do not cause an increased risk of breast cancer. While studies looking at an increased risk of breast cancer with traditional hormone replacement use still do not show a clear consensus, it is generally accepted that there may an increased, albeit small, risk of breast cancer with the use of traditional replacement hormones.
Read More
What Is Inflammatory Breast Cancer?
August 3rd 2011INFLAMMATORY BREAST CANCER (IBC) is an advanced and accelerated form of breast cancer automatically rated as Stage IIIb that usually is not detected by mammograms or ultrasounds. It requires immediate aggressive treatment with chemotherapy prior to surgery and is treated differently than more common types of breast cancer.
Read More
Breast Cancer: A Growing Danger for Overweight Men and Women
August 3rd 2011Talk about breast cancer and naturally, people think of the disease that is the number one cancer among women. But the truth is that breast cancer is on the rise among both women and men, and researchers think the national obesity crisis may be to blame.
Read More
Poll: Will You Recommend Triptorelin to Reproductive-Age Patients With Breast Cancer?
August 2nd 2011Researchers from Italy have found that premenopausal breast cancer patients treated with triptorelin and chemotherapy were less likely to experience early menopause and were more likely to resume menses than patients who received chemotherapy alone.
Read More
Influence of HRT on the Incidence of Breast Cancer
August 2nd 2011Dr. John Collins presented a thorough review of the literature concerning the interaction of hormone replacement and breast cancer entitled "HRT and Breast Cancer: The Evidence and the Issues" with the following general conclusions
Read More
Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology
To review, the recent article in the Lancet that he discussed showed that there was a very small increased risk of breast cancer by taking hormones over a prolonged length of time. However, certainly this risk should be viewed in the overall context of risks and benefits.
Read More
Triptorelin Reduces the Risk of Chemotherapy-Induced Early Menopause
August 2nd 2011The use of chemotherapy for the treatment of breast cancer can result in transient or permanent amenorrhea, and research indicates that each month of chemotherapy translates into 1.5 year of lost reproductive life. This is especially significant for women younger than 40 years, which accounts for 6% of the population diagnosed with breast cancer.
Read More
Beta Blocker Use May Confer Protective Properties for Women With Breast Cancer
August 2nd 2011Recent studies have indicated that β-adrenergic signaling is involved in the regulation of immune responses to breast tumor cells, and data from in vivo studies show an association between β-adrenergic signaling with increased nodal involvement and development of metastasis but no effect on primary tumor growth. Based on this evidence, Dr Thomas I. Barron, from the department of pharmacology and therapeutics at Trinity Centre for Health Sciences, in Dublin, Ireland, and colleagues chose to explore the relationship between beta blocker use and breast tumor characteristics as well as breast cancer morbidity.
Read More
Breast Cancer in Younger Women Assessment and Risk Management
July 28th 2011Breast cancer is a growing concern among premenopausal women. With an emphasis on this patient population, this article discusses the known risk factors for breast cancer; models for quantitative risk assessment; and strategies for modifying breast cancer risk, including screening mammography, prophylactic mastectomy, and primary pharmacologic prevention.
Read More
Hormone Replacement Therapy and Mammogram Accuracy
July 28th 2011A report just published in the Journal of the American Medical Association confirmed previous studies which found that women who take hormone replacement therapy (HRT) may develop denser breast tissue, which in turn may make it more difficult to detect breast cancer through mammography.
Read More
Committee Recommends Withdrawal of Breast Cancer Indication From Bevacizumab
July 25th 2011FDA approval for bevacizumab (Avastin) as treatment for metastatic HER2-negative breast cancer should be withdrawn, according to a unanimous vote (6-0) of the FDA’s Oncologic Drug Advisory Committee. The committee convened at the request of the drugmaker (Genentech) to appeal an earlier decision by the FDA to remove the indication for bevacizumab to treat locally recurrent or metastatic HER2-negative breast cancer.
Read More
Benefits and Challenges of Transitioning Preterm Infants to At-Breast Feedings
July 21st 2011Upon hospital discharge it is not unusual for mothers of preterm infants to continue to meet all or most of their infants' nutritional needs through bottle feedings of expressed breast milk (EBM) because of infants' physiological immaturity and maternal concerns with an inadequacy of milk supply.
Read More